Rigel Pharma is a profitable biotech with three FDA-approved drugs, experiencing accelerating revenue growth led by Tavalisse's strong performance. RIGL trades at a significant discount to biotech ...
Rigel Pharmaceuticals' strategic acquisitions of GAVRETO and REZLIDHIA, along with strong TAVALISSE sales, position the company for significant growth and potential profitability. Despite historical ...
Less than a month and a half from now, on March 3, this column will celebrate its 50th anniversary. I started the column when I was 21, and I'm now 71. But also amazing is the fact that our current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results